Brad has over 30 years of medical device development and venture capital experience. He began his career at Ethicon in R&D and product development working on projects in wound healing, lasers, synthetic vascular prostheses, and absorbable and non-absorbable suture materials for general and microsurgery.

He spent over 20 years in JJDC, Johnson & Johnson’s venture fund, finishing up as head of one of the oldest most successful healthcare venture funds. He co-founded Treo Ventures with Mudit Jain in 2018. Treo is focused on conventional implantable medical devices and neuromodulation.

Treo is excited to be investing in Intervene and looks forward to working with a deeply experienced team to commercialize products for patients dealing venous thrombosis.